BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20521242)

  • 21. Quantitative and qualitative Ductus Venosus blood flow evaluation in the screening for Trisomy 18 and 13 - suitability study.
    Czuba B; Nycz-Reska M; Cnota W; Jagielska A; Wloch A; Borowski D; Wegrzyn P
    Ginekol Pol; 2020; 91(3):144-148. PubMed ID: 32266955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac function in trisomy 21 fetuses.
    Clur SA; Oude Rengerink K; Ottenkamp J; Bilardo CM
    Ultrasound Obstet Gynecol; 2011 Feb; 37(2):163-71. PubMed ID: 20814928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers.
    Borrell A; Gonce A; Martinez JM; Borobio V; Fortuny A; Coll O; Cuckle H
    Prenat Diagn; 2005 Oct; 25(10):901-5. PubMed ID: 16034840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal ductus venosus pulsatility index in the absence of concurrent umbilical vein pulsations does not indicate worsening fetal condition.
    Dahlbäck C; Pihlsgård M; Gudmundsson S
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):322-8. PubMed ID: 23355102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome in fetuses with normal nuchal translucency.
    Oh C; Harman C; Baschat AA
    Ultrasound Obstet Gynecol; 2007 Aug; 30(2):192-6. PubMed ID: 17518423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening performance of congenital heart defects in first trimester using simple cardiac scan, nuchal translucency, abnormal ductus venosus blood flow and tricuspid regurgitation.
    Karadzov Orlic N; Egic A; Damnjanovic-Pazin B; Lukic R; Joksic I; Mikovic Z
    Congenit Heart Dis; 2019 Nov; 14(6):1094-1101. PubMed ID: 31573148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does first-trimester nuchal cord affect the blood flow in the ductus venosus? A prospective observational study.
    Petousis S; Margioula-Siarkou C; Mamopoulos A; Sotiriadis A; Rousso D; Athanasiadis A; Dagklis T
    J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3115-3118. PubMed ID: 28782404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inter- and intra-observer variability in fetal ductus venosus blood flow measurements in high-risk fetuses at 26-32 weeks.
    Bruin CM; Ganzevoort W; Schuit E; Mensing van Charante NA; Wolf H
    Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():67-71. PubMed ID: 31675632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the addition of the ductus venosus useful when screening for aneuploidy and congenital heart disease in fetuses with normal nuchal translucency?
    Prats P; Ferrer Q; Comas C; Rodríguez I
    Fetal Diagn Ther; 2012; 32(1-2):138-43. PubMed ID: 22585666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications.
    Maiz N; Nicolaides KH
    Fetal Diagn Ther; 2010; 28(2):65-71. PubMed ID: 20571255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does abnormal ductus venosus pulsatility index at the first-trimester effect on adverse pregnancy outcomes?
    Yılmaz Baran Ş; Kalaycı H; Doğan Durdağ G; Yetkinel S; Arslan A; Bulgan Kılıçdağ E
    J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101851. PubMed ID: 32623067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ductus venosus blood flow waveform indices of 607 singletons with 133 multiples at 10-14 weeks gestation. An evaluation in uncomplicated pregnancies.
    Germer U; Kohl T; Smrcek JM; Geipel A; Berg C; Krapp M; Friedrich HJ; Diedrich K; Gembruch U
    Arch Gynecol Obstet; 2002 Aug; 266(4):187-92. PubMed ID: 12192475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First trimester ultrasound screening for Down syndrome based on maternal age, fetal nuchal translucency and different combinations of the additional markers nasal bone, tricuspid and ductus venosus flow.
    Abele H; Wagner P; Sonek J; Hoopmann M; Brucker S; Artunc-Ulkumen B; Kagan KO
    Prenat Diagn; 2015 Dec; 35(12):1182-6. PubMed ID: 26223508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome.
    Toyama JM; Brizot ML; Liao AW; Lopes LM; Nomura RM; Saldanha FA; Zugaib M
    Ultrasound Obstet Gynecol; 2004 Apr; 23(4):341-5. PubMed ID: 15065182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population.
    Scott F; Peters H; Bonifacio M; McLennan A; Boogert A; Kesby G; Anderson J
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):205-9. PubMed ID: 15191443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ductus venosus flow velocities in relation to the cardiac defects in first-trimester fetuses with enlarged nuchal translucency.
    Haak MC; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
    Am J Obstet Gynecol; 2003 Mar; 188(3):727-33. PubMed ID: 12634648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation analysis of ductus venosus velocity indices and fetal cardiac function.
    Sanapo L; Turan OM; Turan S; Ton J; Atlas M; Baschat AA
    Ultrasound Obstet Gynecol; 2014 May; 43(5):515-9. PubMed ID: 24186154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.